BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34760702)

  • 1. Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis.
    Khandanpour C; Eisfeld C; Nimmagadda SC; Raab MS; Weinhold N; Seckinger A; Hose D; Jauch A; Försti A; Hemminki K; Hielscher T; Hummel M; Lenz G; Goldschmidt H; Huhn S
    Front Oncol; 2021; 11():757664. PubMed ID: 34760702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS).
    Xie X; Frank D; Patnana PK; Schütte J; Al-Matary Y; Liu L; Wei L; Dugas M; Varghese J; Nimmagadda SC; Khandanpour C
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome.
    Botezatu L; Michel LC; Makishima H; Schroeder T; Germing U; Haas R; van der Reijden B; Marneth AE; Bergevoet SM; Jansen JH; Przychodzen B; Wlodarski M; Niemeyer C; Platzbecker U; Ehninger G; Unnikrishnan A; Beck D; Pimanda J; Hellström-Lindberg E; Malcovati L; Boultwood J; Pellagatti A; Papaemmanuil E; Le Coutre P; Kaeda J; Opalka B; Möröy T; Dührsen U; Maciejewski J; Khandanpour C
    Exp Hematol; 2016 Jul; 44(7):590-595.e1. PubMed ID: 27080012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of the
    Vorwerk J; Sun K; Frank D; Neumann F; Hüve J; Budde PM; Liu L; Xie X; Patnana PK; Ahmed HMM; Opalka B; Lenz G; Jayavelu AK; Khandanpour C
    Front Oncol; 2022; 12():903691. PubMed ID: 36003783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.
    Frank D; Patnana PK; Vorwerk J; Mao L; Gopal LM; Jung N; Hennig T; Ruhnke L; Frenz JM; Kuppusamy M; Autry R; Wei L; Sun K; Mohammed Ahmed HM; Künstner A; Busch H; Müller H; Hutter S; Hoermann G; Liu L; Xie X; Al-Matary Y; Nimmagadda SC; Cano FC; Heuser M; Thol F; Göhring G; Steinemann D; Thomale J; Leitner T; Fischer A; Rad R; Röllig C; Altmann H; Kunadt D; Berdel WE; Hüve J; Neumann F; Klingauf J; Calderon V; Opalka B; Dührsen U; Rosenbauer F; Dugas M; Varghese J; Reinhardt HC; von Bubnoff N; Möröy T; Lenz G; Batcha AMN; Giorgi M; Selvam M; Wang E; McWeeney SK; Tyner JW; Stölzel F; Mann M; Jayavelu AK; Khandanpour C
    Blood; 2023 Dec; 142(25):2175-2191. PubMed ID: 37756525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML.
    Botezatu L; Michel LC; Helness A; Vadnais C; Makishima H; Hönes JM; Robert F; Vassen L; Thivakaran A; Al-Matary Y; Lams RF; Schütte J; Giebel B; Görgens A; Heuser M; Medyouf H; Maciejewski J; Dührsen U; Möröy T; Khandanpour C
    Exp Hematol; 2016 Aug; 44(8):713-726.e14. PubMed ID: 27216773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GFI1 in Epigenetic Regulation of MDS and AML Pathogenesis: Mechanisms and Therapeutic Implications.
    Möröy T; Khandanpour C
    Front Oncol; 2019; 9():824. PubMed ID: 31508375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia.
    Khandanpour C; Thiede C; Valk PJ; Sharif-Askari E; Nückel H; Lohmann D; Horsthemke B; Siffert W; Neubauer A; Grzeschik KH; Bloomfield CD; Marcucci G; Maharry K; Slovak ML; van der Reijden BA; Jansen JH; Schackert HK; Afshar K; Schnittger S; Peeters JK; Kroschinsky F; Ehninger G; Lowenberg B; Dührsen U; Möröy T
    Blood; 2010 Mar; 115(12):2462-72. PubMed ID: 20075157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature.
    Volpe G; Walton DS; Grainger DE; Ward C; Cauchy P; Blakemore D; Coleman DJL; Cockerill PN; Garcia P; Frampton J
    Sci Rep; 2017 Sep; 7(1):11148. PubMed ID: 28894287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GFI1 as a novel prognostic and therapeutic factor for AML/MDS.
    Hönes JM; Botezatu L; Helness A; Vadnais C; Vassen L; Robert F; Hergenhan SM; Thivakaran A; Schütte J; Al-Matary YS; Lams RF; Fraszscak J; Makishima H; Radivoyevitch T; Przychodzen B; da Conceição Castro SV; Görgens A; Giebel B; Klein-Hitpass L; Lennartz K; Heuser M; Thiede C; Ehninger G; Dührsen U; Maciejewski JP; Möröy T; Khandanpour C
    Leukemia; 2016 Jun; 30(6):1237-45. PubMed ID: 26847026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enforced GFI1 expression impedes human and murine leukemic cell growth.
    Hönes JM; Thivakaran A; Botezatu L; Patnana P; Castro SVDC; Al-Matary YS; Schütte J; Fischer KBI; Vassen L; Görgens A; Dührsen U; Giebel B; Khandanpour C
    Sci Rep; 2017 Nov; 7(1):15720. PubMed ID: 29147018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA-650 exerts anti-leukemia activity by inhibiting cell proliferation through Gfi1 targeting.
    Yuan C; Xu L; Du P; Pang J
    Tumori; 2018 Oct; 104(5):369-374. PubMed ID: 28574132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Regulation of Gfi1 in Endocrine-Related Cancers: a Role Regulating Tumor Growth.
    Ashour N; Angulo JC; González-Corpas A; Orea MJ; Lobo MVT; Colomer R; Colás B; Esteller M; Ropero S
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor independence 1 protects hematopoietic stem cells against apoptosis but also prevents the development of a myeloproliferative-like disease.
    Khandanpour C; Kosan C; Gaudreau MC; Dührsen U; Hébert J; Zeng H; Möröy T
    Stem Cells; 2011 Feb; 29(2):376-85. PubMed ID: 21732494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease.
    D'Souza S; del Prete D; Jin S; Sun Q; Huston AJ; Kostov FE; Sammut B; Hong CS; Anderson JL; Patrene KD; Yu S; Velu CS; Xiao G; Grimes HL; Roodman GD; Galson DL
    Blood; 2011 Dec; 118(26):6871-80. PubMed ID: 22042697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1.
    de la Luz Sierra M; Sakakibara S; Gasperini P; Salvucci O; Jiang K; McCormick PJ; Segarra M; Stone J; Maric D; Zhu J; Qian X; Lowy DR; Tosato G
    Blood; 2010 May; 115(19):3970-9. PubMed ID: 20203268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gfi1.1 regulates hematopoietic lineage differentiation during zebrafish embryogenesis.
    Wei W; Wen L; Huang P; Zhang Z; Chen Y; Xiao A; Huang H; Zhu Z; Zhang B; Lin S
    Cell Res; 2008 Jun; 18(6):677-85. PubMed ID: 18504458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GFI1-Dependent Repression of
    Petrusca DN; Mulcrone PL; Macar DA; Bishop RT; Berdyshev E; Suvannasankha A; Anderson JL; Sun Q; Auron PE; Galson DL; Roodman GD
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription Factor ELF1 Activates MEIS1 Transcription and Then Regulates the GFI1/FBW7 Axis to Promote the Development of Glioma.
    Cheng M; Zeng Y; Zhang T; Xu M; Li Z; Wu Y
    Mol Ther Nucleic Acids; 2021 Mar; 23():418-430. PubMed ID: 33473327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
    BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.